(as bibtex)
250 references. 1980-1999
Volumes
1980. Volume
1.
Issues:
_
,
_
1981. Volume
2.
Issues:
_
1982. Volume
3.
Issues:
_
1983. Volume
4.
Issues:
_
1984. Volume
5.
Issues:
_
1985. Volume
6.
Issues:
_
1986. Volume
7.
Issues:
_
1987. Volume
8.
Issues:
_
1988. Volume
9.
Issues:
_
1989. Volume
10.
Issues:
_
1990. Volume
11.
Issues:
_
1991. Volume
12.
Issues:
_
1992. Volume
13.
Issues:
_
1993. Volume
14.
Issues:
_
1994. Volume
15.
Issues:
_
1995. Volume
16.
Issues:
_
1996. Volume
17.
Issues:
_
1997. Volume
18.
Issues:
_
1998. Volume
19.
Issues:
_
1999. Volume
20.
Issues:
_
Recent Articles
-
Thompson, Bruce, Geller, Nancy L., Hunsberger, Sally, Frederick, Margaret, Hill, Robin, Jacob, Rolf G., Smith, Edwin A., Kaufmann, Peter, Freedman, Robert R., Wigley, Fredrick M., Bielory, Leonard.
Behavioral and pharmacologic interventions: The Raynaud's treatment study.
Controlled Clinical Trials
1999.
20:52-63
-
Elbourne, Diana, Garcia, Jo, Snowdon, Claire.
Reply to comment on ``Zelen randomization: Attitudes of parents participating in a neonatal clinical trial''.
Controlled Clinical Trials
1999.
20:571-572
-
Braunholtz, David A..
Comment on ``Zelen randomization: Attitudes of parents participating in a neonatal clinical trial'' (1999V20 p149-171).
Controlled Clinical Trials
1999.
20:569-571
-
Wolfe, Rory, Carlin, John B..
Sample-size calculation for a log-transformed outcome measure.
Controlled Clinical Trials
1999.
20:547-554
-
Fischer-Lapp, Krista, Goetghebeur, Els.
Practical properties of some structural mean analyses of the effect of compliance in randomized trials.
Controlled Clinical Trials
1999.
20:531-546
-
Svolba, Gerhard, Bauer, Peter.
Statistical quality control in clinical trials.
Controlled Clinical Trials
1999.
20:519-530
-
Fisher, Lloyd D..
Comment on ``End-point interpretation in clinical trials: The case for discipline''.
Controlled Clinical Trials
1999.
20:50-51
-
Moye, Lemuel A., Moyé, Lemuel A..
End-point interpretation in clinical trials: The case for discipline (Disc: p50-51).
Controlled Clinical Trials
1999.
20:40-49
-
Shih, Weichung Joe.
Comment on ``Why analysis of variance is inappropriate for multiclinic trials''.
Controlled Clinical Trials
1999.
20:469-471
-
Salsburg, David.
Why analysis of variance is inappropriate for multiclinic trials (Disc: p469-471).
Controlled Clinical Trials
1999.
20:453-468
-
Hueet, Charlotte, Huet, Charlotte, Clark, Heather D., Wells, George A., Huët, Charlotte, McAlister, Finlay A., Salmi, L. Rachid, Fergusson, Dean, Laupacis, Andreas.
Assessing the quality of randomized trials: Reliability of the Jadad scale.
Controlled Clinical Trials
1999.
20:448-452
-
Lesaffre, Emmanuel, Pledger, Gordon.
A note on the number needed to treat.
Controlled Clinical Trials
1999.
20:439-447
-
Gu, Minggao, Lai, Tze Leung.
Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
Controlled Clinical Trials
1999.
20:423-438
-
Lachin, John M..
Worst-rank score analysis with informatively missing observations in clinical trials.
Controlled Clinical Trials
1999.
20:408-422
-
Freidlin, Boris, Korn, Edward L., George, Stephen L..
Data monitoring committees and interim monitoring guidelines.
Controlled Clinical Trials
1999.
20:395-407
-
Fisher, Lloyd D..
Carvedilol and the Food and Drug Administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing.
Controlled Clinical Trials
1999.
20:16-39
-
Doll, Richard, Peto, Richard, Clarke, Michael.
First publication of an individually randomized trial.
Controlled Clinical Trials
1999.
20:367-368
-
Chang, Myron N., Shuster, Jonathan J., Kepner, James L..
Group sequential designs for phase II trials with historical controls.
Controlled Clinical Trials
1999.
20:353-364
-
Liu, P. Y., LeBlanc, Michael, Desai, Manisha.
False positive rates of randomized phase II designs.
Controlled Clinical Trials
1999.
20:343-352
-
Rosenberger, William F..
Randomized play-the-winner clinical trials: Review and recommendations.
Controlled Clinical Trials
1999.
20:328-342
-
Berger, Vance W., Exner, Derek V..
Detecting selection bias in randomized clinical trials.
Controlled Clinical Trials
1999.
20:319-327
-
Heitjan, Daniel F..
Causal inference in a clinical trial: A comparative example.
Controlled Clinical Trials
1999.
20:309-318
-
Gimotty, Phyllis A., Burack, Robert C., George, Julie.
A randomized design for repeated binary outcomes used to evaluate continued effectiveness of a breast cancer control intervention strategy.
Controlled Clinical Trials
1999.
20:280-293
-
Diehr, Paula, Patrick, Donald L., Burke, Gregory L., Williamson, Jeff.
Survival versus years of healthy life: Which is more powerful as a study outcome?.
Controlled Clinical Trials
1999.
20:267-279
-
Ioannidis, John P. A., Dixon, Dennis O., McIntosh, Martin, Albert, Jeffrey M., Bozzette, Samuel A., Schnittman, Steven M..
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: An example from primary {\it Pneumocystis carinii\/} prophylaxis.
Controlled Clinical Trials
1999.
20:253-266